← All stocks

Enliven Therapeutics, Inc.

ELVN Net selling
CIK 0001672619 #1481 in the set updated 22 Sep 2026
Bought (12 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$76.81M
$8.93M on a plan · $15.90M straight out of an exercise
Sold at will
$51.98M
7 of 81 sales
Net
−$76.81M
−$51.98M against sales at will

By person

10 insiders · 83 transactions

There is no salary here to measure against. Enliven Therapeutics, Inc.'s chief executive is paid a token, so dividing a holding by it says nothing.

Which is why this company is in neither direction of the chief executive filter on the transactions page. A stake that cannot be expressed as a multiple is not the same thing as a small one.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
ORBIMED ADVISORS LLC entity
10% owner
$51.68M (6)
−$51.68M
6,555,102
8.95%
$337.47M
−14.8%
Derynck Mika K
Director
$9.56M (1) scheduled
−$9.56M
0
0.0000%
$0.00
Collins Helen Louise
CHIEF MEDICAL OFFICER
$5.39M (24) scheduled
−$5.39M
25,000
0.0341%
$1.29M
Lyssikatos Joseph P
CHIEF SCIENTIFIC OFFICER
$4.91M (13) scheduled
−$4.91M
758,938
1.04%
$39.07M
−29.6%
Patel Anish
CHIEF OPERATING OFFICER
$1.74M (7) scheduled
−$1.74M
235,011
0.3207%
$12.10M
−31.7%
Hohl Benjamin
CHIEF FINANCIAL OFFICER
$1.60M (15) scheduled
−$1.60M
38,000
0.0519%
$1.96M
Kunkel Lori Anne
Director
$850.25K (5) scheduled
−$850.25K
41,884
0.0572%
$2.16M
−8.8%
Kintz Samuel
PRESIDENT AND CEO
$669.70K (4) scheduled
−$669.70K
890,392
1.22%
$45.84M
−15.0%
Heyman Richard A.
Director
$413.38K (6) scheduled
−$413.38K
146,320
0.1997%
$7.53M
−13.4%
Ballal Rahul D.
Director
22,341
0.0305%
$1.15M
0.0%
Insider
Date
Role
Action
Shares
Price
Amount
Collins Helen Louise
17 Sep 2026
CHIEF MEDICAL OFFICER
Sold after exercise
240
$51.48
$12.36K
Collins Helen Louise
17 Sep 2026
CHIEF MEDICAL OFFICER
Sold after exercise
1,844
$50.71
$93.51K
Collins Helen Louise
17 Sep 2026
CHIEF MEDICAL OFFICER
Sold after exercise
2,916
$50.03
$145.89K
Hohl Benjamin
17 Sep 2026
CHIEF FINANCIAL OFFICER
Sold after exercise
289
$51.49
$14.88K
Hohl Benjamin
17 Sep 2026
CHIEF FINANCIAL OFFICER
Sold after exercise
2,194
$50.72
$111.27K
Hohl Benjamin
17 Sep 2026
CHIEF FINANCIAL OFFICER
Sold after exercise
3,535
$50.03
$176.85K
Collins Helen Louise
17 Aug 2026
CHIEF MEDICAL OFFICER
Sold after exercise
1,100
$59.35
$65.28K
Collins Helen Louise
17 Aug 2026
CHIEF MEDICAL OFFICER
Sold after exercise
3,900
$58.37
$227.65K
Derynck Mika K
4 Aug 2026
Director
Sold after exercise
158,795
$60.21
$9.56M
Collins Helen Louise
17 Jul 2026
CHIEF MEDICAL OFFICER
Sold after exercise
63
$53.92
$3.40K
Collins Helen Louise
17 Jul 2026
CHIEF MEDICAL OFFICER
Sold after exercise
2,184
$53.42
$116.67K
Collins Helen Louise
17 Jul 2026
CHIEF MEDICAL OFFICER
Sold after exercise
2,063
$52.39
$108.08K
Collins Helen Louise
17 Jul 2026
CHIEF MEDICAL OFFICER
Sold after exercise
459
$51.55
$23.66K
Collins Helen Louise
17 Jul 2026
CHIEF MEDICAL OFFICER
Sold after exercise
231
$50.05
$11.56K
Hohl Benjamin
17 Jul 2026
CHIEF FINANCIAL OFFICER
Sold after exercise
123
$53.87
$6.63K
Hohl Benjamin
17 Jul 2026
CHIEF FINANCIAL OFFICER
Sold after exercise
2,638
$53.38
$140.82K
Hohl Benjamin
17 Jul 2026
CHIEF FINANCIAL OFFICER
Sold after exercise
2,564
$52.32
$134.14K
Hohl Benjamin
17 Jul 2026
CHIEF FINANCIAL OFFICER
Sold after exercise
369
$51.48
$19.00K
Hohl Benjamin
17 Jul 2026
CHIEF FINANCIAL OFFICER
Sold after exercise
324
$49.97
$16.19K
Collins Helen Louise
17 Jun 2026
CHIEF MEDICAL OFFICER
Sold after exercise
1,133
$44.74
$50.69K
Collins Helen Louise
17 Jun 2026
CHIEF MEDICAL OFFICER
Sold after exercise
2,599
$43.87
$114.02K
Collins Helen Louise
17 Jun 2026
CHIEF MEDICAL OFFICER
Sold after exercise
1,268
$42.83
$54.30K
Hohl Benjamin
17 Jun 2026
CHIEF FINANCIAL OFFICER
Sold after exercise
1,238
$44.75
$55.40K
Hohl Benjamin
17 Jun 2026
CHIEF FINANCIAL OFFICER
Sold after exercise
3,401
$43.86
$149.18K
Hohl Benjamin
17 Jun 2026
CHIEF FINANCIAL OFFICER
Sold after exercise
1,379
$42.79
$59.00K
Collins Helen Louise
18 May 2026
CHIEF MEDICAL OFFICER
Sold after exercise
223
$41.21
$9.19K
Collins Helen Louise
18 May 2026
CHIEF MEDICAL OFFICER
Sold after exercise
1,302
$40.25
$52.40K
Collins Helen Louise
18 May 2026
CHIEF MEDICAL OFFICER
Sold after exercise
3,475
$39.53
$137.38K
Collins Helen Louise
17 Apr 2026
CHIEF MEDICAL OFFICER
Sold after exercise
2,441
$48.06
$117.30K
Collins Helen Louise
17 Apr 2026
CHIEF MEDICAL OFFICER
Sold after exercise
2,419
$47.39
$114.64K
Collins Helen Louise
17 Apr 2026
CHIEF MEDICAL OFFICER
Sold after exercise
140
$45.81
$6.41K
Collins Helen Louise
25 Mar 2026
CHIEF MEDICAL OFFICER
Sold after exercise
40,000
$35.10
$1.40M
Collins Helen Louise
17 Mar 2026
CHIEF MEDICAL OFFICER
Sold after exercise
5,000
$27.76
$138.80K
Collins Helen Louise
10 Mar 2026
CHIEF MEDICAL OFFICER
Sold after exercise
10,129
$30.19
$305.83K
Collins Helen Louise
9 Mar 2026
CHIEF MEDICAL OFFICER
Sold after exercise
29,871
$30.02
$896.81K
Collins Helen Louise
17 Feb 2026
CHIEF MEDICAL OFFICER
Sold after exercise
45,000
$26.17
$1.18M
Hohl Benjamin
29 Sep 2025
CHIEF FINANCIAL OFFICER
Sold after exercise
3,250
$20.40
$66.29K

What was left out

Form 4 filings counted 56
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 2
Sales on a Rule 10b5-1 plan 37
Sales straight out of an exercise 37
Sales at will 7
Transactions with no price 0
Shares from compensation/vesting 450,825
History held since 16 Mar 2020